Home›Search›Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy

Springer Science and Business Media Deutschland GmbH · Germany

ISSN1432-0851

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

1.805

H-Indexi

162

SNIPi

0.987

Total Worksi

7,529

Total Citationsi

236,874

2yr Mean Citednessi

4.53

Open Impact Factor alternative

Aims & Scope

Subject areas: Immunology; Oncology; Cancer Research; Immunology and Allergy; Medicine (miscellaneous).

General Information

Country / RegionGermany

Primary LanguageEnglish

1st Year Published—

FrequencyTwelve No. A Year

StatusActive

Total Publications7,529

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✗ No

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

9/11 · 82%

✅

Do you know the journal / publisher?

Springer Science and Business Media Deutschland GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1432-0851

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

❌

Plagiarism detection in place?

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

165

7.5k

2019

343

12k

2020

320

8.9k

2021

233

2022

223

3.6k

2023

301

3.3k

2024

374

1.7k

2025

262

132

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

ImmunologyQ1

Immunology and AllergyQ1

Medicine (miscellaneous)Q1

OncologyQ1

Subject Classification

Web of Science Categories

ImmunologyOncology

Scopus Categories

ImmunologyCancer ResearchImmunology and AllergyOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Immunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies ResearchImmune cells in cancerGlycosylation and Glycoproteins ResearchImmune Response and InflammationVirus-based gene therapy research

Frequently asked questions about Cancer Immunology, Immunotherapy

Is Cancer Immunology, Immunotherapy a predatory journal?

PubScope has no integrity flags on record for Cancer Immunology, Immunotherapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Immunology, Immunotherapy?

Cancer Immunology, Immunotherapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.53.

Is Cancer Immunology, Immunotherapy indexed in Scopus and Web of Science?

Cancer Immunology, Immunotherapy is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Cancer Immunology, Immunotherapy?